Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of maternal RSV vaccination for preventing respiratory syncytial virus disease in infants.

This is a protocol.

Health topics:

Infectious disease > Vaccination > Other infectious diseases

Published:

21 October 2022

Authors:

Phijffer E, de Bruin O, Wildenbeest JG, Bont LJ, Sturkenboom MCJM, Van der Maas NAT, Ahmadizar F, Bloemenkamp KWM

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Phijffer E, de Bruin O, Wildenbeest JG, Bont LJ, Sturkenboom MCJM, Van der Maas NAT, Ahmadizar F, Bloemenkamp KWM. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 10. Art. No.: CD015134. DOI: 10.1002/14651858.CD015134.